Symbolbild · KI-generiert
Delivra Health Brands Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Helping people take control of their health with alternative wellness solutions is what energizes the Delivra Health team! The Delivra Health portfolio features innovative brands like Dream Water¿ and LivRelief¿, which deliver relief from common everyday issues like chronic pain, anxiety, and sleeplessness. Delivra Health products have allowed millions of customers to reclaim their mobility, energy, and in turn, quality of life. The websites of the Company's two subsidiaries are Dream Water¿ and LivRelief TM. For more information, please visit www.delivrahealthbrands.com.
Company description as published by the issuer via TMX Money.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Delivra Health Brands Inc. | DHB | TSXV | 2 Mio. USD |
| Nugen Medical Devices Inc. | NGMD | TSXV | 2 Mio. USD |
| Quest PharmaTech Inc. | QPT | TSXV | 2 Mio. USD |
| Therma Bright Inc. | THRM | TSXV | 2 Mio. USD |
| Cannibble Food-Tech Ltd | PLCN | CSE | 2 Mio. USD |
| Zero Candida Technologies Inc. | ZCT | TSXV | 2 Mio. USD |
| Rakovina Therapeutics Inc. | RKV | TSXV | 2 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.